Picture2.png
Teknova Reports First Quarter 2022 Financial Results
May 11, 2022 16:01 ET | Alpha Teknova, Inc.
First quarter 2022 total revenue was $11.1 million, up 23% year-over-yearExcluding Sample Transport revenue, first quarter 2022 total revenue was $11.1 million, up 37% year-over-yearStrong cash...
Picture2.png
Teknova to Report First Quarter 2022 Financial Results on May 11, 2022
May 04, 2022 17:18 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of...
Picture2.png
Teknova Reports Fourth Quarter and Full Year 2021 Financial Results
March 15, 2022 16:01 ET | Alpha Teknova, Inc.
     Full year 2021 total revenue was $36.9 million, up 18% year-over-yearExcluding Sample Transport revenue of $1.5 million, full year 2021 total revenue was $35.4 million, up 31%...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
March 02, 2022 08:05 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova Announces Preliminary Revenue of $10.0 to $10.1 Million for the Fourth Quarter 2021
February 28, 2022 08:15 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova to Participate in Upcoming Investor Conference
February 14, 2022 08:00 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova to Join the Nasdaq Biotechnology Index
December 15, 2021 18:02 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova to Participate in Upcoming Investor Conferences
November 16, 2021 17:03 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova Reports Third Quarter 2021 Financial Results
November 10, 2021 16:01 ET | Alpha Teknova, Inc.
$9.4 million in total revenue, up 5% year-over-yearExcluding Sample Transport, total revenue was $9.3 million, up 26% year-over-yearStrong cash position of $98.0 million supports investment in...
Ken Gelhaus
Teknova Expands Leadership Team with the Appointments of Ken Gelhaus as Chief Commercial Officer and Jennifer Henry as Senior Vice President, Marketing
November 10, 2021 07:00 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading manufacturer of cell culture media and supplements, protein purification buffers, and...